Citius Pharmaceuticals, Inc. Cash and Restricted Cash
Citius Pharmaceuticals, Inc. (CTXR) had Cash and Restricted Cash of $17.01 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $17.01M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.59M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.72M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.25M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $17.01M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $4.59M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $7.72M 10-Q · filed 2026-02-13 |
| 2025-09-30 | $4.25M 10-Q · filed 2026-08-14 |
| 2025-06-30 | $6.09M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $26.41K 10-Q · filed 2026-05-15 |
| 2024-12-31 | $1.10M 10-Q · filed 2026-02-13 |
| 2024-09-30 | $3.25M 10-Q · filed 2026-08-14 |
| 2024-06-30 | $17.91M 10-Q · filed 2025-08-12 |
| 2024-03-31 | $12.56M 10-Q · filed 2025-05-14 |
| 2023-12-31 | $20.35M 10-Q · filed 2025-02-14 |
| 2023-09-30 | $26.48M 10-K · filed 2025-12-23 |
| 2023-06-30 | $33.28M 10-Q · filed 2024-08-12 |
| 2023-03-31 | $29.07M 10-Q · filed 2024-05-14 |
| 2022-12-31 | $36.89M 10-Q · filed 2024-02-14 |
| 2022-09-30 | $41.71M 10-K · filed 2024-12-27 |
| 2022-06-30 | $48.04M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $55.76M 10-Q · filed 2023-05-12 |
| 2021-12-31 | $65.42M 10-Q · filed 2023-02-10 |
| 2021-09-30 | $70.07M 10-K · filed 2023-12-29 |
| 2021-06-30 | $115.66M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $103.70M 10-Q · filed 2022-05-12 |
| 2020-09-30 | $13.86M 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |